Drug recall · May 5, 2021
Betamethasone Dipropionate Ointment USP recall
Why: Failed Impurities/ Degradation Specifications - OOS for know impurity Betamethasone 17- propionate.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Betamethasone Dipropionate Ointment USP, 0.05% (Augmented), packaged in 15 grams tubes, Manufactured by: Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-019-15
- Lots / codes
Lot #: 14297, Exp 9/2021; 15372, Exp 3/2022; 15841, Exp 8/2022
- Quantity
- 104,784 tubes
- Company
- Teligent Pharma, Inc., Buena, NJ
- Distribution
- USA Nationwide
- Initiated
- February 2, 2021 · Voluntary: Firm initiated
- Classified
- April 23, 2021
- Reported
- May 5, 2021
- Ended
- August 15, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Betamethasone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.